FDA notes heart events, tumors with Novo drug

(AP) -- Federal health officials say a potential blockbuster diabetes drug from Novo Nordisk appears to work. But they say questions remain about its effect on the heart and other organs.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news157716529.html">FDA notes heart events, tumors with Novo drug</a></p> <p>(AP) -- Federal health officials say a potential blockbuster diabetes drug from Novo Nordisk appears to work. But they say questions remain about its effect on the heart and other organs.</p>